Drugs Made In America Acquisition Corp.
DMAA
$10.27
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.11% | -35.71% | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | -30.24% | 1,847.22% | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | -30.00% | 1,320.00% | |||
|
|
|||||
| Total Current Assets | -30.00% | 1,320.00% | |||
| Net Property, Plant & Equipment | -- | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 1.04% | 42,541.17% | |||
| Total Assets | 1.03% | 42,166.98% | |||
|
|
|||||
| Total Accounts Payable | -- | -- | |||
| Total Accrued Expenses | -- | 71.41% | |||
| Short-term Debt | -- | -90.80% | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | -- | |||
| Total Finance Division Other Current Liabilities | 0.00% | 174.51% | |||
| Total Other Current Liabilities | 0.00% | 174.51% | |||
| Total Current Liabilities | -13.24% | -56.34% | |||
|
|
|||||
| Total Current Liabilities | -13.24% | -56.34% | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -90.80% | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | 1.01% | -- | |||
| Total Liabilities | 0.99% | 30,059.96% | |||
|
|
|||||
| Common Stock & APIC | 0.00% | -96.86% | |||
| Retained Earnings | -2.09% | -2,160.54% | |||
| Treasury Stock & Other | 18.37% | -- | |||
| Total Common Equity | 0.34% | -2,831.54% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | 0.34% | -2,831.54% | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 0.34% | -2,831.54% | |||
|
|
|||||